A detailed history of Five Oceans Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Five Oceans Advisors holds 3,763 shares of MRK stock, worth $373,214. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,763
Previous 3,125 20.42%
Holding current value
$373,214
Previous $386,000 10.62%
% of portfolio
0.23%
Previous 0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$111.15 - $128.97 $70,913 - $82,282
638 Added 20.42%
3,763 $427,000
Q2 2024

Jul 10, 2024

SELL
$123.8 - $132.96 $3,714 - $3,988
-30 Reduced 0.95%
3,125 $386,000
Q1 2024

Apr 16, 2024

BUY
$113.24 - $131.95 $5,322 - $6,201
47 Added 1.51%
3,155 $416,000
Q4 2023

Jan 22, 2024

SELL
$100.18 - $109.02 $14,125 - $15,371
-141 Reduced 4.34%
3,108 $338,000
Q3 2023

Oct 17, 2023

SELL
$102.95 - $114.33 $1,338 - $1,486
-13 Reduced 0.4%
3,249 $334,000
Q2 2023

Jul 14, 2023

SELL
$108.61 - $118.38 $6,625 - $7,221
-61 Reduced 1.84%
3,262 $376,000
Q1 2023

Apr 14, 2023

BUY
$102.94 - $114.86 $308 - $344
3 Added 0.09%
3,323 $353,000
Q4 2022

Jan 17, 2023

SELL
$87.44 - $112.11 $1,486 - $1,905
-17 Reduced 0.51%
3,320 $0
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $26,626 - $29,912
315 Added 10.42%
3,337 $287,000
Q2 2022

Jul 15, 2022

BUY
$83.49 - $94.64 $17,449 - $19,779
209 Added 7.43%
3,022 $276,000
Q1 2022

Apr 19, 2022

BUY
$73.51 - $82.4 $2,205 - $2,472
30 Added 1.08%
2,813 $231,000
Q4 2021

Jan 14, 2022

BUY
$72.28 - $90.54 $3,830 - $4,798
53 Added 1.94%
2,783 $213,000
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $195,686 - $215,205
2,730 New
2,730 $205,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Five Oceans Advisors Portfolio

Follow Five Oceans Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Five Oceans Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Five Oceans Advisors with notifications on news.